Skip to main content
. 2021 Sep 3;15(1):79–94. doi: 10.1093/ckj/sfab161

FIGURE 2:

FIGURE 2:

FIGURE 2:

FIGURE 2:

Association of recent use of RAASi (A), ACEi (B) or ARB (C) users versus non-users with the risk of COVID-19 infection, stratified by different variables. Estimates are presented for the age-, sex- and propensity score-matched samples. N. Treatments, number of concomitant pharmacological treatments; COVID-19 impact, estimated prevalence of COVID-19 at the corresponding healthcare area.